Studying the Role of Microglial LXR in Control of AD Risk Genes

Anna Podlesny-Drabiniok, PhD Icahn School of Medicine at Mount Sinai


Alison Goate, PhD


The goal of this project is to generate and functionally characterize hiPSC-derived microglia lacking transcription factors involved in lipid-clearance machinery in disease-relevant context. I aim to understand how transcription factors that regulate lipid clearance machinery control microglial functions in AD brains. To this end, I will generate human microglia (iMGL) derived from induced pluripotent stem cells that lack LXRa and LXRb as well as iMGL that lack repressors of LXRa/b to address potential gain of LXR function in disease-relevant context. I will further characterize function of modified iMGL in vitro and in specialized mouse models looking at microglial recruitment to plaques, phagocytosis, lipid clearance processes and impact on neurodegeneration.

Project Details

Unique aspect of this proposal is to address cell-autonomous role of LXRa and LXRb in human microglia that has not been investigated yet. This work will also help to elucidate the role of lipid clearance machinery and its impact on disease-associated microglia in AD models. Finally, generated human induced pluripotent stem cells (hiPSC) lacking LXRa/b or their repressor will be valuable tool to study role of these transcription factors in other cell types by differentiation neurons, astrocytes and oligodendrocytes. Completing this project will shed a new light on microglial role of LXRs in control of lipid clearance and immune response in normal and diseased AD brains. This work may open new avenues for therapeutic intervention for AD. Additionally, this work may also uncover which transcription factor controls transition from homeostatic to disease-associated microglia – a population of microglia frequently found in neurodegeneration – what will further help to prioritize small molecules targeting this population.